Abstract
Targeting omicron and other reported SARS-CoV-2 lineages by potent inhibitors of main protease 3CL Mpro: Molecular simulation analysis
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
https://doi.org/10.1016/j.jinf.2022.02.012
Journal: The Journal of infection | Publication Date: Feb 17, 2022 |
Citations: 3 | License type: NO-CC CODE |
Targeting omicron and other reported SARS-CoV-2 lineages by potent inhibitors of main protease 3CL Mpro: Molecular simulation analysis
Join us for a 30 min session where you can share your feedback and ask us any queries you have